An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of uncertain source.
Several professionals stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.
Digital Marketplace Operations
Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.
Within moments of entering one group, a vendor posted contact information, where the majority of purchases take place. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, messages display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Although the research behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly significant medical dangers”.
